Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 2

439 - The miR-22 targets the truncated neurokinin-1 receptor expression in breast cancer cell


20 Dec 2015


Poster presentation 2


Yunli Zhou


Annals of Oncology (2015) 26 (suppl_9): 16-33. 10.1093/annonc/mdv519


Y. Zhou

Author affiliations

  • Clinical Laboratory, Tianjin Medical University Cancer Institute and Hospital, 300060 - Tianjin/CN


Abstract 439


Previous studies in breast cancer cell lines demonstrated that truncated neurokinin receptor-1 (NK1R-Tr) was able to promote malignant transformation and distant metastasis in human breast cancer. Bioinformatics analyses revealed that NK1R-Tr 3'UTR contained putative miR-22 binding sites. The aim of the present study is to explore the role of miR-22 in regulating the NK1R-Tr expression in breast cancer cells.


We assessed the miR-22 and NK1R-Tr expression patterns in three breast cancer cell lines and 98 clinical biopsies. Using luciferase constructs containing the 3'-UTR of NK1R-Tr sequence, pre-miR-22 and antagomiR-22 were conducted to breast cancer cell lines to investigate the interaction between NK1R-Tr and miR-22.


Test on breast cancer tissues showed that lower expression of NK1R-Tr corresponded to higher expression of miR-22. MiR-22 expressions were significantly decreased in tumor specimens, particularly in metastatic carcinomas. MiR-22 levels were higher in SK-BR-3 cells which NK1R-Tr were low expression than MB-MDA-231 and MCF-7 cells which NK1R-Tr were high expression. Transfection of MDA-MB-231 cells with pre-miR-22 or antagomiR-22 was specifically decreased or increased, respectively, NK1R-Tr mRNA levels the same. Overexpression of pre-miR-22 reduced NK1R-Tr protein levels. Reporter constructs containing the NK1R-Tr binding sites inserted into the 3'-untranslated region of the luciferase mRNA conferred a 2.8 fold repression of luciferase activity, in MDA-MB-231 cells. MiR-22 expression was strongly inhibited by NK1R agonist substance P (SP), in MDA-MB-231 cells. Our in vitro data showed that MiR-22 expression was inversely associated with proliferation, invasiveness and metastasis of MDA-MB-231 cells, but inhibited by NK1R agonists was able to promote tumor progression and promote distant metastasis in human breast cancer.


Our data demonstrate that miR-22 can regulate NK1R-Tr expression and influence invasion and migration of breast cancer cells.

Clinical trial identification


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings